MANSFIELD, Mass.--(BUSINESS WIRE)--Dec. 30, 2013--
(NYSE: COV), a leading global provider of healthcare products, will
present at the 32nd Annual J.P. Morgan Healthcare Conference
in San Francisco on January 13, 2014. Joe Almeida, Chairman, President
and Chief Executive Officer, will discuss the company in a presentation
scheduled to begin at 8:30 a.m. PT (11:30 a.m. ET).
A live audio webcast of the presentation can be accessed at Covidien’s
Investor Relations website: http://investor.covidien.com.
An archived edition of the presentation will be available following the
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien develops,
manufactures and sells a diverse range of industry-leading medical
device and supply products. With 2013 revenue of $10.2 billion, Covidien
has more than 38,000 employees worldwide in more than 70 countries, and
its products are sold in over 150 countries. Please visit www.covidien.com
to learn more about our business.
Peter Lucht, 508-452-4168
Lannum, CFA, 508-452-4343